In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies

International Journal of Antimicrobial Agents

Volumn 39, Issue 5, 2012, Pages 440-443

  Colozza, Camilla ^a   Posteraro, Brunella ^b   Santilli, Stefania ^a   De Carolis, Elena ^b   Sanguinetti, Maurizio ^b   Girmenia, Corrado ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

AmBisome; Amphotericin B; Aspergillus spp.; Haematological malignancies; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BROTH DILUTION; CANCER PATIENT; CONTROLLED STUDY; DRUG SCREENING; EPSILOMETER TEST; FUNGUS ISOLATION; HEMATOLOGIC MALIGNANCY; HUMAN; IN VITRO STUDY; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; DRUG RESISTANCE, FUNGAL; HEMATOLOGIC NEOPLASMS; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS;

EID: 84859424219     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.01.013     Document Type: Article

References (15)

1. J.P. Adler-Moore, and R.T. Proffitt Amphotericin B lipid preparations: what are the differences? Clin Microbiol Infect 14 2008 25 36 (Pubitemid 351593914)
2. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
3. C. Lass-Flörl, G. Kofler, G. Kropshofer, J. Hermans, A. Kreczy, and M.P. Dierich In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis J Antimicrob Chemother 42 1998 497 502 (Pubitemid 28473010)
4. D.P. Kontoyiannis, R.E. Lewis, G.S. May, N. Osherov, and M.G. Rinaldi Aspergillus nidulans is frequently resistant to amphotericin B Mycoses 45 2002 406 407 (Pubitemid 35357014)
5. C. Lass-Flörl, A. Mayr, S. Perkhofer, G. Hinterberger, J. Hausdorfer, and C. Speth Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing Antimicrob Agents Chemother 52 2008 3637 3641
6. K.L. Oakley, C.B. Moore, and D.W. Denning Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole Antimicrob Agents Chemother 43 1999 1264 1266 (Pubitemid 29214759)
7. L. Alcazar-Fuoli, E. Mellado, A. Alastruey-Izquierdo, M. Cuenca-Estrella, and J.L. Rodriguez-Tudela Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification Antimicrob Agents Chemother 52 2008 1244 1251 (Pubitemid 351521983)
8. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 2nd ed. Document M38-A2. Wayne, PA: CLSI; 2008.
9. E. De Carolis, B. Posteraro, C. Lass-Flörl, A. Vella, A.R. Florio, and R. Torelli Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry Clin Microbiol Infect 2011 [Epub ahead of print]
10. J. Guinea, T. Peláez, L. Alcalá, and E. Bouza Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus Diagn Microbiol Infect Dis 57 2007 273 276 (Pubitemid 46330656)
11. E. Martín-Mazuelos, J. Pemán, A. Valverde, M. Chaves, M.C. Serrano, and E. Cantón Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 52 2003 365 370 (Pubitemid 37120713)
12. J. Meletiadis, J.W. Mouton, J.F. Meis, B.A. Bouman, and P.E. Verweij Comparison of the Etest and the Sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species J Clin Microbiol 40 2002 2876 2885 (Pubitemid 35284956)
13. C. Lass-Flörl, and S. Perkhofer In vitro susceptibility-testing in Aspergillus species Mycoses 51 2008 437 446
14. F.C. Odds, F. Van Gerven, A. Espinel-Ingroff, M.S. Bartlett, M.A. Ghannoum, and M.V. Lancaster Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models Antimicrob Agents Chemother 42 1998 282 288 (Pubitemid 28114432)
15. E. Dannaoui, E. Borel, F. Persat, M.A. Piens, and S. Picot Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis J Med Microbiol 49 2000 601 606 (Pubitemid 30447273)